Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases

Journal of the American Academy of Dermatology

Volumn 41, Issue 4, 1999, Pages 533-539

  Metze, D ^a   Reimann, S ^a   Beissert, S ^a   Luger, T ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; NEMEXIN; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEARTBURN; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NAUSEA; PRIORITY JOURNAL; PRURIGO; PRURITUS; TACHYPHYLAXIS; VERTIGO;

EID: 0032860968     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)80048-6     Document Type: Article

References (37)

1. Greaves MW Pruritus Champion RH Burton JL Ebling FJG Textbook of dermatology 1992 Blackwell Scientific Publications Oxford 527 535
2. Denman ST A review of pruritus J Am Acad Dermatol 14 1986 375 392
3. Bernhard JD Itch: mechanisms and management of pruritus 1994 McGraw-Hill New York
4. Handwerker HO Forster C Kirchhoff C Discharge patterns of human C-fibers induced by itching and burning stimuli J Neurophysiol 66 1991 307 315
5. Schmelz M Schmidt R Bickel A Handwerker HO Torebjörk HE Specific C-receptors for itching in human skin J Neurosci 17 1997 8003 8008
6. Greaves MW Wall PD Pathophysiology of itching Lancet 348 1996 938 940
7. Wahlgren C-F Pathophysiology of itching in urticaria and atopic dermatitis Allergy 47 1992 65 75
8. Summerfield JA Naloxone modulates the perception of itch in man Br J Clin Pharmacol 10 1980 180 183
9. Bernstein JE Grinzi RA Butorphanol-induced pruritus antagonized by naloxone J Am Acad Dermatol 5 1981 227 228
10. Fjellner B Hägermark Ö Potentiation of histamine-induced itch and flare response in human skin by the enkephalin analogue FK 33-824, beta-endorphin, and morphine Arch Dermatol Res 274 1982 29 37
11. Stein C The control of pain in peripheral tissue by opioids N Engl J Med 332 1995 1685 1690
12. Bernstein JE Swift RM Soltani K Lorincz AL Antipruritic effect of an opiate antagonist, naloxone hydrochloride J Invest Dermatol 78 1982 82 83
13. Heyer G Dotzer M Diepgen TL Handwerker HO Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis Pain 73 1997 239 243
14. Penning JP Samson B Baxter AD Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine Can J Anaesth 35 1988 559 604
15. Bernstein JE Relief of intractable pruritus with naloxone Arch Dermatol 115 1979 1366 1367
16. Jones EA Bergasa NV The pruritus of cholestasis and the opioid system JAMA 268 1992 3359 3362
17. Wolfhagen FH Sternieri E Hop WC Vitale G Bertolotti M Van Buuren HR Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study Gastroenterology 113 1997 1264 1269
18. Bergasa NV Schmitt JM Talbot TL Alling DW Swain MG Turner ML Open-label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 27 1998 679 684
19. Thornton JR Losowsky MS Opioid peptides and primary biliary cirrhosis Br Med J 297 1998 1501 1504
20. Summerfield JA Pain, itch, and endorphins Br J Dermatol 105 1981 725 726
21. Peer G Kivity S Agami O Fireman E Silverberg D Blum M Randomised crossover trial of naltrexone in uraemic pruritus Lancet 348 1996 1552 1554
22. Ghura HS Patterson AD Carmichael AJ Natrexone in the treatment of renal itch Br J Dermatol 139 suppl 51 1998 64
23. Monroe EW Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis J Am Acad Dermatol 21 1989 135 136
24. Banerjii D Fox R Seleznick M Controlled antipruritic trial of nalmefene in chronic urticaria and atopic dermatitis J Allergy Clin Immunol 81 1988 252
25. Burch JR Harrison PV Opiates, sleep, and itch Clin Exp Dermatol 13 1988 418 419
26. Hägermark Ö Wahlgren C-F Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms J Dermatol Sci 4 1992 55 62
27. Aitken RCB Measurement of feelings using visual analogue scales Proc R Soc Med 62 1969 989 993
28. Epstein E Pinski JB A blind study Arch Dermatol 89 1964 548 549
29. Metze D Reimann S Szepfalusi Z Bohle B Kraft D Luger TA Persistent pruritus after hydroxyethyl starch (HES) infusion: a result of long-term storage in cutaneous nerves Br J Dermatol 136 1997 553 559
30. Szeimies RM Stolz W Wlotzke U Korting HC Landthaler M Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin Br J Dermatol 131 1994 380 382
31. Wolf R Krakowski A Variations in aquagenic pruritus and treatment alternatives J Am Acad Dermatol 18 1988 1081 1083
32. Lamberg SI Green SB Byar DP Block JB Clendenning WE Epstein EH Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooprative Group Cancer Treat Rep 63 1979 701 707
33. Bernhard JD Macular amyloidosus, notalgia paresthetical and pruritus: Three sides of the same coin? Dermatology 183 1991 53
34. [letter] Harrison PVJ Nalmefene and pruritus J Am Acad Dermatol 23 1990 530
35. [letter reply] Monroe EW Nalmefene and pruritus J Am Acad Dermatol 23 1990 530
36. Gonzalez JP Brodgen RN A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence Drugs 35 1988 192 213
37. Croop RS Faulkner EB Labriola DF The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. The Naltrexone Usage Study Group Arch Gen Psychiatry 54 1997 1130 1135